Torrent Pharma's attempt to acquire the stake of the Hamied family in Cipla has hit a roadblock due to differences in valuation. Talks between the two parties have been suspended, but may resume if they can agree on a valuation. Other potential buyers have also been deterred by the rising valuations of Cipla shares. Torrent Pharma had been working on a $7 billion acquisition financing package for the deal.